Medical Affairs > Patient Advocacy

Patient Advocacy Research

Best Practices in Working with Patient Advocacy Groups: Building Effective Relationships 
Patient and professional advocacy groups play a crucial role in educating the marketplace on new medicines and treatments... (ID SM-185)
Companies Profiled: Abaxis, Abbott Laboratories, Allos Therapeutics, Amgen, more ...
Price: $7500.00   Free Excerpt Available

Collaborating with Patient Advocacy Groups to Educate the Marketplace 
Strong relationships with advocacy groups are fundamental for educating the public on most recent medical happenings, especially on socially-sensitive conditions and treatment options... (ID PSM-242)
Companies Profiled: Abbott Laboratories, Baxter Healthcare, Solvay Pharmaceuticals, Vital Therapies, more ...
Price: $6500.00   Free Excerpt Available

Medical Affairs' Role in Patient Engagement Activities 
The medical affairs function continues its evolution from a support-only function into an independent role, one that is critical to the success of pharmaceutical companies... (ID POP-280)
Companies Profiled: Abbvie, Actelion, Alkermes, AstraZeneca, more ...
Price: $5800.00   Free Excerpt Available

Advocacy Excellence: Optimizing Group Structure & Operations 
Alliances with patient advocacy groups play an important role in educating the marketplace about new and existing therapies... (ID PSM-253)
Companies Profiled: Abbott, Genomic Health, Boehringer Ingelheim, Amgen, more ...
Price: $5100.00   Free Excerpt Available

Collaborating with Patient Advocacy Groups to Educate the Marketplace 
Patient and Professional Advocacy Groups are an important part of the process by which the marketplace is educated on new medicines and treatments... (ID PSM-330)
Companies Profiled: Alnylam Pharmaceuticals, Astellas, Baldwin Area Medical Center, Bayer, more ...
Price: $4000.00   Free Excerpt Available

Soliris: Translating Groundbreaking Science into a Successful Orphan Drug 
The only FDA approved treatment for life-threatening ultra-rare disorders - paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), Soliris (eculizumab) - developed by Alexion Pharmaceuticals, gained substantial benefits from its orphan drug status, clinical effectiveness and first-to-market status... (ID PSM-342)
Companies Profiled: Alexion Pharmaceuticals, Epirus Biopharmaceuticals, Amgen
Price: $2500.00   Free Excerpt Available

Patient-Focused Support: How Government Affairs & Public Policy Groups Support the Patient Journey 
Patient advocacy is a critical success factor in the health care industry... (ID PSM-307)
Companies Profiled: Boehringer Ingelheim, Dr Reddy's Laboratories, GlaxoSmithKline , Shire, more ...
Price: $2500.00   Free Excerpt Available


Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information